Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
LETTERS TO THE EDITOR

Cross-Reactivity of Current Serogroup 6 Factor Sera from Statens Serum Institut with the Recently Described Pneumococcal Serotype 6D

Preston E. Bratcher, Moon H. Nahm
Preston E. Bratcher
Departments of Microbiology and Pathology University of Alabama at Birmingham 845 19th Street South, BBRB614 Birmingham, Alabama 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moon H. Nahm
Departments of Microbiology and Pathology University of Alabama at Birmingham 845 19th Street South, BBRB614 Birmingham, Alabama 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nahm@uab.edu
DOI: 10.1128/JCM.00839-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A recent study by Jacobs et al. (3) examined the specificity of a newly introduced pneumococcal capsule-specific antiserum (factor serum 6d) manufactured by Statens Serum Institut (SSI) in Denmark. The factor serum 6d was designed to be specific for serotype 6C, a newly described pneumococcal serotype (5), and was to complement factor sera 6b and 6c, which are designed to be specific for pneumococcal serotypes 6A and 6B, respectively. While Jacobs et al. confirmed the designed specificity of the factor serum 6d for serotype 6C using the standard Quellung reaction, the study did not examine the specificity of the factor serum for the novel 6D serotype, which was previously predicted (2) but was only recently found in nature (1, 4). We have therefore investigated the specificity of the currently available serogroup 6 factor sera with serotype 6D using the standard Quellung reaction, an agglutination assay, and a flow cytometric assay.

The three SSI serogroup 6 rabbit factor sera (6b [lot L6b22A1], 6c [lot H6c11E1], and 6d [lot L6d11C1]) were purchased from Mira Vista Diagnostics in March of 2010. The 6b factor serum was manufactured using the protocol revised in January 2009 and was absorbed with serotype 6C according to SSI (personal communication). Initially, we tested the factor sera using the Quellung reaction and four pneumococcal strains, TIGR6A, -B, -C, and -D, which are artificially created pneumococcal strains in the TIGR4 background that express pneumococcal capsule types 6A, 6B, 6C, and 6D, respectively (2). Using the Quellung reaction, we found that factor sera 6b, 6c, and 6d reacted with serotypes 6A, 6B, and 6C, respectively, while both factor sera 6c and 6d also reacted with serotype 6D (Table 1). To further investigate the seroreactivity of these factor sera, we tested the sera with flow cytometry and agglutination assays. The agglutination assay was independently performed by three individuals who were blinded to the identities of the three factor sera and eight bacterial strains (Table 2). The bacterial strains consisted of four clinical isolates representing the four serotypes and the TIGR6A, -B, -C, and -D strains. Again, we found that factor sera 6b, 6c, and 6d reacted with serotypes 6A, 6B, and 6C, respectively (Table 2), although one operator scored the reaction of TIGR6C with factor serum 6c as positive. As a result of this discrepancy, 12 additional clinical 6C strains were tested with factor serum 6c. Eleven of these were scored as negative, and one was scored as weakly positive. We also found that factor sera 6c and 6d reacted with serotype 6D, although there was some disagreement with the TIGR6D strain and factor serum 6c. Overall, the agglutination test results closely resembled the Quellung reaction results, and serotype 6D seems to react positively with both factor sera 6c and 6d.

Flow cytometry was performed as previously described (1), using the factor sera at a 1:50 dilution and goat anti-rabbit R-phycoerythrin conjugate (Southern Biotech). We considered staining under 30 fluorescence units to be negative, and there is moderate staining of some factor sera for multiple serotypes. However, the moderate staining may not be meaningful since these factor sera are not meant for use in flow cytometry. The more meaningful results may be the strong staining (more than 300 fluorescence units) produced by the factor sera (Fig. 1). With strong staining as the selection criterion, the factor sera bound to the expected serotypes: factor serum 6d bound to 6C, and factor sera 6c and 6d reacted with serotype 6D, similar to the Quellung reaction results. Taken together, our results confirm and extend the findings of Jacobs et al. by showing that the currently available factor sera 6c and 6d may cross-react with serotype 6D. Furthermore, their cross-reaction may be useful in the serological identification of serotype 6D. However, this cross-reaction with 6D may vary among reagent lots since the currently available factor sera may not be tested for cross-reaction with serotype 6D.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Results of flow cytometry performed with pneumococcal strains TIGR6A, -B, -C, and -D. Controls included are None (no primary antibody) and NRS (normal, unimmunized rabbit serum). 6b, 6c, and 6d represent factor sera 6b, 6c, and 6d, respectively.

View this table:
  • View inline
  • View popup
TABLE 1.

Specificity of the serogroup 6 factor sera in the Quellung test

View this table:
  • View inline
  • View popup
TABLE 2.

Specificity of serogroup 6 factor sera in the agglutination test

ACKNOWLEDGMENTS

This work was supported by NIH funding (AI-031473) to M.H.N.

  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Bratcher, P. E., K. H. Kim, J. H. Kang, J. Y. Hong, and M. H. Nahm. 2010. Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology 156 : 555-560.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Bratcher, P. E., I. H. Park, S. K. Hollingshead, and M. H. Nahm. 2009. Production of a unique pneumococcal capsule serotype belonging to serogroup 6. Microbiology 155 : 576-583.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Jacobs, M. R., R. Dagan, S. Bajaksouzian, A. R. Windau, and N. Porat. 2010. Validation of factor 6d antiserum for serotyping Streptococcus pneumoniae serotype 6C. J. Clin. Microbiol. 48 : 1456-1457.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Jin, P., F. Kong, M. Xiao, S. Oftadeh, F. Zhou, C. Liu, F. Russell, and G. L. Gilbert. 2009. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J. Infect. Dis. 200 : 1375-1380.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Park, I. H., D. G. Pritchard, R. Cartee, A. Brandao, M. C. Brandileone, and M. H. Nahm. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45 : 1225-1233.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Cross-Reactivity of Current Serogroup 6 Factor Sera from Statens Serum Institut with the Recently Described Pneumococcal Serotype 6D
Preston E. Bratcher, Moon H. Nahm
Journal of Clinical Microbiology Jul 2010, 48 (8) 3044-3045; DOI: 10.1128/JCM.00839-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cross-Reactivity of Current Serogroup 6 Factor Sera from Statens Serum Institut with the Recently Described Pneumococcal Serotype 6D
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cross-Reactivity of Current Serogroup 6 Factor Sera from Statens Serum Institut with the Recently Described Pneumococcal Serotype 6D
Preston E. Bratcher, Moon H. Nahm
Journal of Clinical Microbiology Jul 2010, 48 (8) 3044-3045; DOI: 10.1128/JCM.00839-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ACKNOWLEDGMENTS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Antibodies, Bacterial
bacteriological techniques
Pneumococcal Infections
Streptococcus pneumoniae

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X